1 |
L. W. Fu, Y. M. Zhang, Y. J. Liang, X. P. Yang, and Q. C. Pan, The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer, 38, 418-426 (2002)
DOI
ScienceOn
|
2 |
O. Fardel, V. Lecureur, and A. Guillouzo, The P-glycoprotein multidrug transporter, Gen. Pharmacol., 27, 1283-1291 (1996)
DOI
ScienceOn
|
3 |
S. Labialle, L. Gayet, E. Marthinet, D. Rigal, and L. G. Baggetto, Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem. Pharmacol., 64, 943-948 (2002)
DOI
ScienceOn
|
4 |
A. F. Castro and G. A. Altenberg, Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein, Biochem. Pharmacol., 53, 89-93 (1997)
DOI
ScienceOn
|
5 |
S. Y. Chung, M. K. Sung, N. H. Kim, J. O. Jang, E. J. Go, and H. J. Lee, Inhibition of P-glycoprotein by natural products in human breast cancer cells, Arch. Pharm. Res., 28, 823-828 (2005)
과학기술학회마을
DOI
ScienceOn
|
6 |
S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, and M. M. Gottesman, Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annu. Rev. Pharmacol. Toxicol., 39, 361-398 (1999)
DOI
ScienceOn
|
7 |
H. R. Kim, S. Y. Chung, Y. H. Jeong, E. J. Go, A.-R. Han, N. H. Kim, M. K. Sung, G. Song, J. O. Jang, J.-W. Nam, H. J. Lee, and E.-K. Seo, P-glycoprotein inhibitory activity of Indonesian medicinal plants in human breast cancer cells, Nat. Prod. Sci., 10, 268-271 (2004)
|
8 |
P. K. Smith, R. I. Krohn, G.. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk, Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85 (1985)
DOI
ScienceOn
|
9 |
R. L. Juliano and I. Pastan, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochim. Biophys. Acta, 455, 152-162 (1976)
DOI
ScienceOn
|
10 |
N. Kartner, J. R. Riordan, and V. Ling, Cell surface P-glycoprotein associated with multidrug resistance in mam- malian cell lines, Science, 221, 1285-1288 (1983)
DOI
|
11 |
A. Boumendjel, A. Di Pietro, C. Dumontet, and D. Baarron, Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med. Res. Rev., 22, 512-529 (2002)
DOI
ScienceOn
|
12 |
G. Conseil, H. Baubichon-Cortay, G. Dayan, J. M. Jault, G. Comte, D. Barron, and A. di Pietro, Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid- binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. USA, 95, 9831-9836 (1998)
|
13 |
Z. E. Sauna, M. M. Smith, M. Muller, K. M. Kerr, and S. V. Ambudkar, The mechanism of action of multidrug-resistance-linked P-glycoprotein. J. Bioenerg. Biomembr., 33, 481-491 (2001)
DOI
ScienceOn
|
14 |
L. Urbatsch Ina, and B. Sankaran, P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J. Bio. Chem., 270, 19383-19390 (1995)
DOI
ScienceOn
|
15 |
S. Anuchapreeda, P. Leechanachai, M. M. Smith, S. V. Ambudkar and P. N. Limtrakul, Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells, Biochem. Pharmacol., 64, 573-582 (2002)
DOI
ScienceOn
|
16 |
A. E. Senior, M. K. al-Shawi, and I. L. Urbatsch, The catalytic cycle of P-glycoprotein. FEBS Lett., 377, 285-289 (1995)
DOI
ScienceOn
|
17 |
M. Raderer and W. Scheitharuer, Clinical trials of agents that reverse multidrug resistance, Cancer, 72, 3553-3563 (1993)
DOI
ScienceOn
|
18 |
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer. Institute, 82, 1107-1112 (1990)
DOI
|